New Vaccine Technologies to Combat Outbreak Situations.
Identifieur interne : 000985 ( PubMed/Checkpoint ); précédent : 000984; suivant : 000986New Vaccine Technologies to Combat Outbreak Situations.
Auteurs : Susanne Rauch [Allemagne] ; Edith Jasny [Allemagne] ; Kim E. Schmidt [Allemagne] ; Benjamin Petsch [Allemagne]Source :
- Frontiers in immunology [ 1664-3224 ] ; 2018.
Descripteurs français
- KwdFr :
- Animaux, Contrôle des maladies contagieuses (), Contrôle des maladies contagieuses (tendances), Flambées de maladies (), Humains, Maladies transmissibles (), Maladies transmissibles (immunologie), Maladies transmissibles (épidémiologie), Santé mondiale, Vaccination (), Vaccination (tendances), Vaccins (administration et posologie), Vaccins (immunologie).
- MESH :
- administration et posologie : Vaccins.
- immunologie : Maladies transmissibles, Vaccins.
- tendances : Contrôle des maladies contagieuses, Vaccination.
- épidémiologie : Maladies transmissibles.
- Animaux, Contrôle des maladies contagieuses, Flambées de maladies, Humains, Maladies transmissibles, Santé mondiale, Vaccination.
English descriptors
- KwdEn :
- Animals, Communicable Disease Control (methods), Communicable Disease Control (trends), Communicable Diseases (epidemiology), Communicable Diseases (immunology), Communicable Diseases (therapy), Disease Outbreaks (prevention & control), Global Health, Humans, Vaccination (methods), Vaccination (trends), Vaccines (administration & dosage), Vaccines (immunology).
- MESH :
- chemical , administration & dosage : Vaccines.
- epidemiology : Communicable Diseases.
- immunology : Communicable Diseases, Vaccines.
- methods : Communicable Disease Control, Vaccination.
- prevention & control : Disease Outbreaks.
- therapy : Communicable Diseases.
- trends : Communicable Disease Control, Vaccination.
- Animals, Global Health, Humans.
Abstract
Ever since the development of the first vaccine more than 200 years ago, vaccinations have greatly decreased the burden of infectious diseases worldwide, famously leading to the eradication of small pox and allowing the restriction of diseases such as polio, tetanus, diphtheria, and measles. A multitude of research efforts focuses on the improvement of established and the discovery of new vaccines such as the HPV (human papilloma virus) vaccine in 2006. However, radical changes in the density, age distribution and traveling habits of the population worldwide as well as the changing climate favor the emergence of old and new pathogens that bear the risk of becoming pandemic threats. In recent years, the rapid spread of severe infections such as HIV, SARS, Ebola, and Zika have highlighted the dire need for global preparedness for pandemics, which necessitates the extremely rapid development and comprehensive distribution of vaccines against potentially previously unknown pathogens. What is more, the emergence of antibiotic resistant bacteria calls for new approaches to prevent infections. Given these changes, established methods for the identification of new vaccine candidates are no longer sufficient to ensure global protection. Hence, new vaccine technologies able to achieve rapid development as well as large scale production are of pivotal importance. This review will discuss viral vector and nucleic acid-based vaccines (DNA and mRNA vaccines) as new approaches that might be able to tackle these challenges to global health.
DOI: 10.3389/fimmu.2018.01963
PubMed: 30283434
Affiliations:
Links toward previous steps (curation, corpus...)
Links to Exploration step
pubmed:30283434Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">New Vaccine Technologies to Combat Outbreak Situations.</title><author><name sortKey="Rauch, Susanne" sort="Rauch, Susanne" uniqKey="Rauch S" first="Susanne" last="Rauch">Susanne Rauch</name><affiliation wicri:level="3"><nlm:affiliation>CureVac AG, Tuebingen, Germany.</nlm:affiliation><country xml:lang="fr">Allemagne</country><wicri:regionArea>CureVac AG, Tuebingen</wicri:regionArea><placeName><region type="land" nuts="1">Bade-Wurtemberg</region><region type="district" nuts="2">District de Tübingen</region><settlement type="city">Tübingen</settlement></placeName></affiliation></author><author><name sortKey="Jasny, Edith" sort="Jasny, Edith" uniqKey="Jasny E" first="Edith" last="Jasny">Edith Jasny</name><affiliation wicri:level="3"><nlm:affiliation>CureVac AG, Tuebingen, Germany.</nlm:affiliation><country xml:lang="fr">Allemagne</country><wicri:regionArea>CureVac AG, Tuebingen</wicri:regionArea><placeName><region type="land" nuts="1">Bade-Wurtemberg</region><region type="district" nuts="2">District de Tübingen</region><settlement type="city">Tübingen</settlement></placeName></affiliation></author><author><name sortKey="Schmidt, Kim E" sort="Schmidt, Kim E" uniqKey="Schmidt K" first="Kim E" last="Schmidt">Kim E. Schmidt</name><affiliation wicri:level="3"><nlm:affiliation>CureVac AG, Tuebingen, Germany.</nlm:affiliation><country xml:lang="fr">Allemagne</country><wicri:regionArea>CureVac AG, Tuebingen</wicri:regionArea><placeName><region type="land" nuts="1">Bade-Wurtemberg</region><region type="district" nuts="2">District de Tübingen</region><settlement type="city">Tübingen</settlement></placeName></affiliation></author><author><name sortKey="Petsch, Benjamin" sort="Petsch, Benjamin" uniqKey="Petsch B" first="Benjamin" last="Petsch">Benjamin Petsch</name><affiliation wicri:level="3"><nlm:affiliation>CureVac AG, Tuebingen, Germany.</nlm:affiliation><country xml:lang="fr">Allemagne</country><wicri:regionArea>CureVac AG, Tuebingen</wicri:regionArea><placeName><region type="land" nuts="1">Bade-Wurtemberg</region><region type="district" nuts="2">District de Tübingen</region><settlement type="city">Tübingen</settlement></placeName></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2018">2018</date><idno type="RBID">pubmed:30283434</idno><idno type="pmid">30283434</idno><idno type="doi">10.3389/fimmu.2018.01963</idno><idno type="wicri:Area/PubMed/Corpus">000969</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000969</idno><idno type="wicri:Area/PubMed/Curation">000969</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000969</idno><idno type="wicri:Area/PubMed/Checkpoint">000985</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000985</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">New Vaccine Technologies to Combat Outbreak Situations.</title><author><name sortKey="Rauch, Susanne" sort="Rauch, Susanne" uniqKey="Rauch S" first="Susanne" last="Rauch">Susanne Rauch</name><affiliation wicri:level="3"><nlm:affiliation>CureVac AG, Tuebingen, Germany.</nlm:affiliation><country xml:lang="fr">Allemagne</country><wicri:regionArea>CureVac AG, Tuebingen</wicri:regionArea><placeName><region type="land" nuts="1">Bade-Wurtemberg</region><region type="district" nuts="2">District de Tübingen</region><settlement type="city">Tübingen</settlement></placeName></affiliation></author><author><name sortKey="Jasny, Edith" sort="Jasny, Edith" uniqKey="Jasny E" first="Edith" last="Jasny">Edith Jasny</name><affiliation wicri:level="3"><nlm:affiliation>CureVac AG, Tuebingen, Germany.</nlm:affiliation><country xml:lang="fr">Allemagne</country><wicri:regionArea>CureVac AG, Tuebingen</wicri:regionArea><placeName><region type="land" nuts="1">Bade-Wurtemberg</region><region type="district" nuts="2">District de Tübingen</region><settlement type="city">Tübingen</settlement></placeName></affiliation></author><author><name sortKey="Schmidt, Kim E" sort="Schmidt, Kim E" uniqKey="Schmidt K" first="Kim E" last="Schmidt">Kim E. Schmidt</name><affiliation wicri:level="3"><nlm:affiliation>CureVac AG, Tuebingen, Germany.</nlm:affiliation><country xml:lang="fr">Allemagne</country><wicri:regionArea>CureVac AG, Tuebingen</wicri:regionArea><placeName><region type="land" nuts="1">Bade-Wurtemberg</region><region type="district" nuts="2">District de Tübingen</region><settlement type="city">Tübingen</settlement></placeName></affiliation></author><author><name sortKey="Petsch, Benjamin" sort="Petsch, Benjamin" uniqKey="Petsch B" first="Benjamin" last="Petsch">Benjamin Petsch</name><affiliation wicri:level="3"><nlm:affiliation>CureVac AG, Tuebingen, Germany.</nlm:affiliation><country xml:lang="fr">Allemagne</country><wicri:regionArea>CureVac AG, Tuebingen</wicri:regionArea><placeName><region type="land" nuts="1">Bade-Wurtemberg</region><region type="district" nuts="2">District de Tübingen</region><settlement type="city">Tübingen</settlement></placeName></affiliation></author></analytic><series><title level="j">Frontiers in immunology</title><idno type="eISSN">1664-3224</idno><imprint><date when="2018" type="published">2018</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Animals</term><term>Communicable Disease Control (methods)</term><term>Communicable Disease Control (trends)</term><term>Communicable Diseases (epidemiology)</term><term>Communicable Diseases (immunology)</term><term>Communicable Diseases (therapy)</term><term>Disease Outbreaks (prevention & control)</term><term>Global Health</term><term>Humans</term><term>Vaccination (methods)</term><term>Vaccination (trends)</term><term>Vaccines (administration & dosage)</term><term>Vaccines (immunology)</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Animaux</term><term>Contrôle des maladies contagieuses ()</term><term>Contrôle des maladies contagieuses (tendances)</term><term>Flambées de maladies ()</term><term>Humains</term><term>Maladies transmissibles ()</term><term>Maladies transmissibles (immunologie)</term><term>Maladies transmissibles (épidémiologie)</term><term>Santé mondiale</term><term>Vaccination ()</term><term>Vaccination (tendances)</term><term>Vaccins (administration et posologie)</term><term>Vaccins (immunologie)</term></keywords><keywords scheme="MESH" type="chemical" qualifier="administration & dosage" xml:lang="en"><term>Vaccines</term></keywords><keywords scheme="MESH" qualifier="administration et posologie" xml:lang="fr"><term>Vaccins</term></keywords><keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>Communicable Diseases</term></keywords><keywords scheme="MESH" qualifier="immunologie" xml:lang="fr"><term>Maladies transmissibles</term><term>Vaccins</term></keywords><keywords scheme="MESH" qualifier="immunology" xml:lang="en"><term>Communicable Diseases</term><term>Vaccines</term></keywords><keywords scheme="MESH" qualifier="methods" xml:lang="en"><term>Communicable Disease Control</term><term>Vaccination</term></keywords><keywords scheme="MESH" qualifier="prevention & control" xml:lang="en"><term>Disease Outbreaks</term></keywords><keywords scheme="MESH" qualifier="tendances" xml:lang="fr"><term>Contrôle des maladies contagieuses</term><term>Vaccination</term></keywords><keywords scheme="MESH" qualifier="therapy" xml:lang="en"><term>Communicable Diseases</term></keywords><keywords scheme="MESH" qualifier="trends" xml:lang="en"><term>Communicable Disease Control</term><term>Vaccination</term></keywords><keywords scheme="MESH" qualifier="épidémiologie" xml:lang="fr"><term>Maladies transmissibles</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Animals</term><term>Global Health</term><term>Humans</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Animaux</term><term>Contrôle des maladies contagieuses</term><term>Flambées de maladies</term><term>Humains</term><term>Maladies transmissibles</term><term>Santé mondiale</term><term>Vaccination</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Ever since the development of the first vaccine more than 200 years ago, vaccinations have greatly decreased the burden of infectious diseases worldwide, famously leading to the eradication of small pox and allowing the restriction of diseases such as polio, tetanus, diphtheria, and measles. A multitude of research efforts focuses on the improvement of established and the discovery of new vaccines such as the HPV (human papilloma virus) vaccine in 2006. However, radical changes in the density, age distribution and traveling habits of the population worldwide as well as the changing climate favor the emergence of old and new pathogens that bear the risk of becoming pandemic threats. In recent years, the rapid spread of severe infections such as HIV, SARS, Ebola, and Zika have highlighted the dire need for global preparedness for pandemics, which necessitates the extremely rapid development and comprehensive distribution of vaccines against potentially previously unknown pathogens. What is more, the emergence of antibiotic resistant bacteria calls for new approaches to prevent infections. Given these changes, established methods for the identification of new vaccine candidates are no longer sufficient to ensure global protection. Hence, new vaccine technologies able to achieve rapid development as well as large scale production are of pivotal importance. This review will discuss viral vector and nucleic acid-based vaccines (DNA and mRNA vaccines) as new approaches that might be able to tackle these challenges to global health.</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">30283434</PMID><DateCompleted><Year>2019</Year><Month>09</Month><Day>30</Day></DateCompleted><DateRevised><Year>2019</Year><Month>09</Month><Day>30</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1664-3224</ISSN><JournalIssue CitedMedium="Internet"><Volume>9</Volume><PubDate><Year>2018</Year></PubDate></JournalIssue><Title>Frontiers in immunology</Title><ISOAbbreviation>Front Immunol</ISOAbbreviation></Journal><ArticleTitle>New Vaccine Technologies to Combat Outbreak Situations.</ArticleTitle><Pagination><MedlinePgn>1963</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.3389/fimmu.2018.01963</ELocationID><Abstract><AbstractText>Ever since the development of the first vaccine more than 200 years ago, vaccinations have greatly decreased the burden of infectious diseases worldwide, famously leading to the eradication of small pox and allowing the restriction of diseases such as polio, tetanus, diphtheria, and measles. A multitude of research efforts focuses on the improvement of established and the discovery of new vaccines such as the HPV (human papilloma virus) vaccine in 2006. However, radical changes in the density, age distribution and traveling habits of the population worldwide as well as the changing climate favor the emergence of old and new pathogens that bear the risk of becoming pandemic threats. In recent years, the rapid spread of severe infections such as HIV, SARS, Ebola, and Zika have highlighted the dire need for global preparedness for pandemics, which necessitates the extremely rapid development and comprehensive distribution of vaccines against potentially previously unknown pathogens. What is more, the emergence of antibiotic resistant bacteria calls for new approaches to prevent infections. Given these changes, established methods for the identification of new vaccine candidates are no longer sufficient to ensure global protection. Hence, new vaccine technologies able to achieve rapid development as well as large scale production are of pivotal importance. This review will discuss viral vector and nucleic acid-based vaccines (DNA and mRNA vaccines) as new approaches that might be able to tackle these challenges to global health.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Rauch</LastName><ForeName>Susanne</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>CureVac AG, Tuebingen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jasny</LastName><ForeName>Edith</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>CureVac AG, Tuebingen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schmidt</LastName><ForeName>Kim E</ForeName><Initials>KE</Initials><AffiliationInfo><Affiliation>CureVac AG, Tuebingen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Petsch</LastName><ForeName>Benjamin</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>CureVac AG, Tuebingen, Germany.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>09</Month><Day>19</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Immunol</MedlineTA><NlmUniqueID>101560960</NlmUniqueID><ISSNLinking>1664-3224</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014612">Vaccines</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003140" MajorTopicYN="N">Communicable Disease Control</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName><QualifierName UI="Q000639" MajorTopicYN="N">trends</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003141" MajorTopicYN="N">Communicable Diseases</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004196" MajorTopicYN="N">Disease Outbreaks</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention & control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014943" MajorTopicYN="N">Global Health</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014611" MajorTopicYN="N">Vaccination</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName><QualifierName UI="Q000639" MajorTopicYN="N">trends</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014612" MajorTopicYN="N">Vaccines</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration & dosage</QualifierName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="Y">DNA vaccine</Keyword><Keyword MajorTopicYN="Y">mRNA vaccine</Keyword><Keyword MajorTopicYN="Y">pandemics</Keyword><Keyword MajorTopicYN="Y">vaccine development</Keyword><Keyword MajorTopicYN="Y">viral vector vaccine</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2018</Year><Month>05</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>08</Month><Day>09</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>10</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>10</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>10</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30283434</ArticleId><ArticleId IdType="doi">10.3389/fimmu.2018.01963</ArticleId><ArticleId IdType="pmc">PMC6156540</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Lancet Infect Dis. 2015 May;15(5):519-27</Citation><ArticleIdList><ArticleId IdType="pubmed">25739878</ArticleId></ArticleIdList></Reference><Reference><Citation>Curr Gene Ther. 2013 Dec;13(6):385-94</Citation><ArticleIdList><ArticleId IdType="pubmed">24195604</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 2000 Nov 30;408(6812):605-9</Citation><ArticleIdList><ArticleId IdType="pubmed">11117750</ArticleId></ArticleIdList></Reference><Reference><Citation>Science. 2013 May 31;340(6136):1232910</Citation><ArticleIdList><ArticleId IdType="pubmed">23723240</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaccine. 2013 Mar 25;31(13):1752-8</Citation><ArticleIdList><ArticleId IdType="pubmed">23357198</ArticleId></ArticleIdList></Reference><Reference><Citation>Virology. 1998 Jun 20;246(1):134-44</Citation><ArticleIdList><ArticleId IdType="pubmed">9657001</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet. 2015 Apr 18;385(9977):1545-54</Citation><ArticleIdList><ArticleId IdType="pubmed">25540891</ArticleId></ArticleIdList></Reference><Reference><Citation>Blood. 2006 Dec 15;108(13):4009-17</Citation><ArticleIdList><ArticleId IdType="pubmed">16940422</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur J Biochem. 2001 Apr;268(7):1908-17</Citation><ArticleIdList><ArticleId IdType="pubmed">11277913</ArticleId></ArticleIdList></Reference><Reference><Citation>Hum Vaccin. 2010 Jun;6(6):439-49</Citation><ArticleIdList><ArticleId IdType="pubmed">20671437</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2003 May 15;348(20):1967-76</Citation><ArticleIdList><ArticleId IdType="pubmed">12690091</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS Negl Trop Dis. 2016 Jun 23;10(6):e0004746</Citation><ArticleIdList><ArticleId IdType="pubmed">27336830</ArticleId></ArticleIdList></Reference><Reference><Citation>IUBMB Life. 2017 May;69(5):297-304</Citation><ArticleIdList><ArticleId IdType="pubmed">28374903</ArticleId></ArticleIdList></Reference><Reference><Citation>Bull Hist Med. 2002 Spring;76(1):105-15</Citation><ArticleIdList><ArticleId IdType="pubmed">11875246</ArticleId></ArticleIdList></Reference><Reference><Citation>J Exp Med. 1996 Oct 1;184(4):1555-60</Citation><ArticleIdList><ArticleId IdType="pubmed">8879229</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaccine. 2016 Dec 12;34(51):6617-6625</Citation><ArticleIdList><ArticleId IdType="pubmed">27317264</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS Med. 2006 Jun;3(6):e177</Citation><ArticleIdList><ArticleId IdType="pubmed">16683867</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaccine. 2016 Oct 26;34(45):5410-5413</Citation><ArticleIdList><ArticleId IdType="pubmed">27531411</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2015 Apr 17;10(4):e0123969</Citation><ArticleIdList><ArticleId IdType="pubmed">25884189</ArticleId></ArticleIdList></Reference><Reference><Citation>Hum Vaccin Immunother. 2014;10(10):2875-84</Citation><ArticleIdList><ArticleId IdType="pubmed">25483662</ArticleId></ArticleIdList></Reference><Reference><Citation>Sci Rep. 2016 Mar 02;6:22509</Citation><ArticleIdList><ArticleId IdType="pubmed">26931556</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaccine. 2010 Dec 16;29(2):304-13</Citation><ArticleIdList><ArticleId IdType="pubmed">21034824</ArticleId></ArticleIdList></Reference><Reference><Citation>Front Immunol. 2017 Nov 13;8:1539</Citation><ArticleIdList><ArticleId IdType="pubmed">29181005</ArticleId></ArticleIdList></Reference><Reference><Citation>Blood. 1985 Nov;66(5):1149-54</Citation><ArticleIdList><ArticleId IdType="pubmed">4052630</ArticleId></ArticleIdList></Reference><Reference><Citation>Methods Mol Biol. 2017;1499:109-121</Citation><ArticleIdList><ArticleId IdType="pubmed">27987145</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2017 Oct 12;377(15):1438-1447</Citation><ArticleIdList><ArticleId IdType="pubmed">29020589</ArticleId></ArticleIdList></Reference><Reference><Citation>Ther Deliv. 2016;7(5):319-34</Citation><ArticleIdList><ArticleId IdType="pubmed">27075952</ArticleId></ArticleIdList></Reference><Reference><Citation>Expert Rev Vaccines. 2016;15(3):313-29</Citation><ArticleIdList><ArticleId IdType="pubmed">26707950</ArticleId></ArticleIdList></Reference><Reference><Citation>Gene Ther. 2004 Apr;11(8):711-21</Citation><ArticleIdList><ArticleId IdType="pubmed">14724672</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaccine. 2007 Apr 20;25(16):2974-83</Citation><ArticleIdList><ArticleId IdType="pubmed">17303293</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet. 2015 Aug 29;386(9996):857-66</Citation><ArticleIdList><ArticleId IdType="pubmed">26248676</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur J Immunol. 2005 Sep;35(9):2532-40</Citation><ArticleIdList><ArticleId IdType="pubmed">16144036</ArticleId></ArticleIdList></Reference><Reference><Citation>Cancer Immunol Immunother. 2016 Sep;65(9):1075-83</Citation><ArticleIdList><ArticleId IdType="pubmed">27422115</ArticleId></ArticleIdList></Reference><Reference><Citation>Cell. 2017 Jul 13;170(2):273-283.e12</Citation><ArticleIdList><ArticleId IdType="pubmed">28708997</ArticleId></ArticleIdList></Reference><Reference><Citation>Intervirology. 2000;43(4-6):273-81</Citation><ArticleIdList><ArticleId IdType="pubmed">11251382</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2012;7(1):e29732</Citation><ArticleIdList><ArticleId IdType="pubmed">22238645</ArticleId></ArticleIdList></Reference><Reference><Citation>Mol Ther. 2017 Jun 7;25(6):1316-1327</Citation><ArticleIdList><ArticleId IdType="pubmed">28457665</ArticleId></ArticleIdList></Reference><Reference><Citation>Gene. 1995 Nov 20;165(2):233-8</Citation><ArticleIdList><ArticleId IdType="pubmed">8522182</ArticleId></ArticleIdList></Reference><Reference><Citation>Virus Genes. 2017 Oct;53(5):733-740</Citation><ArticleIdList><ArticleId IdType="pubmed">28710608</ArticleId></ArticleIdList></Reference><Reference><Citation>Mol Ther Methods Clin Dev. 2016 Apr 27;3:16030</Citation><ArticleIdList><ArticleId IdType="pubmed">27162933</ArticleId></ArticleIdList></Reference><Reference><Citation>J Virol. 2003 Oct;77(19):10394-403</Citation><ArticleIdList><ArticleId IdType="pubmed">12970424</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Med. 2014 Oct;20(10):1126-9</Citation><ArticleIdList><ArticleId IdType="pubmed">25194571</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc Natl Acad Sci U S A. 2016 Jul 19;113(29):E4133-42</Citation><ArticleIdList><ArticleId IdType="pubmed">27382155</ArticleId></ArticleIdList></Reference><Reference><Citation>Gene Ther. 2014 Jul;21(7):645-52</Citation><ArticleIdList><ArticleId IdType="pubmed">24830436</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2016 Apr 28;374(17):1635-46</Citation><ArticleIdList><ArticleId IdType="pubmed">25629663</ArticleId></ArticleIdList></Reference><Reference><Citation>J Virol. 2005 Dec;79(24):15107-13</Citation><ArticleIdList><ArticleId IdType="pubmed">16306582</ArticleId></ArticleIdList></Reference><Reference><Citation>Mol Med. 1997 Jun;3(6):362-71</Citation><ArticleIdList><ArticleId IdType="pubmed">9234241</ArticleId></ArticleIdList></Reference><Reference><Citation>Curr Opin Immunol. 2011 Jun;23(3):421-9</Citation><ArticleIdList><ArticleId IdType="pubmed">21530212</ArticleId></ArticleIdList></Reference><Reference><Citation>J Gene Med. 2012 Jun;14(6):428-39</Citation><ArticleIdList><ArticleId IdType="pubmed">22262664</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet Respir Med. 2018 Feb;6(2):94-95</Citation><ArticleIdList><ArticleId IdType="pubmed">29169772</ArticleId></ArticleIdList></Reference><Reference><Citation>Expert Rev Vaccines. 2016 Sep;15(9):1101-12</Citation><ArticleIdList><ArticleId IdType="pubmed">27160784</ArticleId></ArticleIdList></Reference><Reference><Citation>Cell. 2017 Mar 9;168(6):1114-1125.e10</Citation><ArticleIdList><ArticleId IdType="pubmed">28222903</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet Infect Dis. 2016 Jan;16(1):31-42</Citation><ArticleIdList><ArticleId IdType="pubmed">26546548</ArticleId></ArticleIdList></Reference><Reference><Citation>J Biol Chem. 1980 Feb 10;255(3):903-8</Citation><ArticleIdList><ArticleId IdType="pubmed">6243301</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet. 2015 Jun 6;385(9984):2272-9</Citation><ArticleIdList><ArticleId IdType="pubmed">25817373</ArticleId></ArticleIdList></Reference><Reference><Citation>NPJ Vaccines. 2017 Oct 19;2:29</Citation><ArticleIdList><ArticleId IdType="pubmed">29263884</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Intern Med. 2016 Mar 1;164(5):313-22</Citation><ArticleIdList><ArticleId IdType="pubmed">26833336</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaccine. 2016 Dec 12;34(51):6597-6609</Citation><ArticleIdList><ArticleId IdType="pubmed">27395563</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaccines (Basel). 2013 Jun 25;1(3):225-49</Citation><ArticleIdList><ArticleId IdType="pubmed">26344110</ArticleId></ArticleIdList></Reference><Reference><Citation>Cancer Res. 2010 Nov 15;70(22):9031-40</Citation><ArticleIdList><ArticleId IdType="pubmed">21045153</ArticleId></ArticleIdList></Reference><Reference><Citation>Sci Rep. 2017 Mar 21;7(1):252</Citation><ArticleIdList><ArticleId IdType="pubmed">28325910</ArticleId></ArticleIdList></Reference><Reference><Citation>Immunology. 2018 Jan;153(1):1-9</Citation><ArticleIdList><ArticleId IdType="pubmed">28869761</ArticleId></ArticleIdList></Reference><Reference><Citation>J Infect Dis. 2017 Dec 16;216(suppl_10):S957-S963</Citation><ArticleIdList><ArticleId IdType="pubmed">29267918</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc Natl Acad Sci U S A. 2004 Feb 17;101(7):1951-6</Citation><ArticleIdList><ArticleId IdType="pubmed">14769933</ArticleId></ArticleIdList></Reference><Reference><Citation>J Virol. 2013 Jan;87(2):1019-34</Citation><ArticleIdList><ArticleId IdType="pubmed">23135719</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaccine. 2016 Jul 19;34(33):3882-93</Citation><ArticleIdList><ArticleId IdType="pubmed">27269061</ArticleId></ArticleIdList></Reference><Reference><Citation>Science. 1990 Mar 23;247(4949 Pt 1):1465-8</Citation><ArticleIdList><ArticleId IdType="pubmed">1690918</ArticleId></ArticleIdList></Reference><Reference><Citation>Adv Genet. 2015;89:179-233</Citation><ArticleIdList><ArticleId IdType="pubmed">25620012</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaccine. 2017 Jul 24;35(33):4064-4071</Citation><ArticleIdList><ArticleId IdType="pubmed">28647170</ArticleId></ArticleIdList></Reference><Reference><Citation>Trans R Soc Trop Med Hyg. 1953 Jan;47(1):13-48</Citation><ArticleIdList><ArticleId IdType="pubmed">13077697</ArticleId></ArticleIdList></Reference><Reference><Citation>J Control Release. 2015 Nov 10;217:345-51</Citation><ArticleIdList><ArticleId IdType="pubmed">26264835</ArticleId></ArticleIdList></Reference><Reference><Citation>Curr Opin Virol. 2017 Apr;23:88-94</Citation><ArticleIdList><ArticleId IdType="pubmed">28460340</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Diagn Lab Immunol. 2003 May;10(3):411-6</Citation><ArticleIdList><ArticleId IdType="pubmed">12738640</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaccine. 2018 Jan 29;36(5):683-690</Citation><ArticleIdList><ArticleId IdType="pubmed">29287681</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2017 Oct 4;:null</Citation><ArticleIdList><ArticleId IdType="pubmed">28976850</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur J Immunol. 2005 May;35(5):1557-66</Citation><ArticleIdList><ArticleId IdType="pubmed">15832293</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Commun. 2017 Mar 02;8:14630</Citation><ArticleIdList><ArticleId IdType="pubmed">28251988</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 2017 Jul 13;547(7662):222-226</Citation><ArticleIdList><ArticleId IdType="pubmed">28678784</ArticleId></ArticleIdList></Reference><Reference><Citation>J Infect Dis. 2008 Jun 15;197(12):1643-52</Citation><ArticleIdList><ArticleId IdType="pubmed">18513153</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Struct Mol Biol. 2004 Feb;11(2):121-7</Citation><ArticleIdList><ArticleId IdType="pubmed">14749774</ArticleId></ArticleIdList></Reference><Reference><Citation>Science. 2015 Aug 14;349(6249):739-42</Citation><ArticleIdList><ArticleId IdType="pubmed">26249231</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2017 Mar 9;376(10):928-938</Citation><ArticleIdList><ArticleId IdType="pubmed">25426834</ArticleId></ArticleIdList></Reference><Reference><Citation>Cell Mol Life Sci. 2004 Sep;61(18):2418-24</Citation><ArticleIdList><ArticleId IdType="pubmed">15378210</ArticleId></ArticleIdList></Reference><Reference><Citation>Hum Vaccin Immunother. 2012 Nov 1;8(11):1703-6</Citation><ArticleIdList><ArticleId IdType="pubmed">22922764</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet. 2017 Feb 4;389(10068):505-518</Citation><ArticleIdList><ArticleId IdType="pubmed">28017403</ArticleId></ArticleIdList></Reference><Reference><Citation>Mol Ther. 2008 Nov;16(11):1833-40</Citation><ArticleIdList><ArticleId IdType="pubmed">18797453</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 2003 Aug 7;424(6949):681-4</Citation><ArticleIdList><ArticleId IdType="pubmed">12904795</ArticleId></ArticleIdList></Reference><Reference><Citation>Curr Gene Ther. 2013 Dec;13(6):421-33</Citation><ArticleIdList><ArticleId IdType="pubmed">24279313</ArticleId></ArticleIdList></Reference><Reference><Citation>Hum Vaccin. 2006 Mar-Apr;2(2):45-53</Citation><ArticleIdList><ArticleId IdType="pubmed">17012886</ArticleId></ArticleIdList></Reference><Reference><Citation>J Infect Dis. 2016 Oct 15;214(suppl 3):S360-S366</Citation><ArticleIdList><ArticleId IdType="pubmed">27496978</ArticleId></ArticleIdList></Reference><Reference><Citation>Hum Vaccin Immunother. 2018;14(9):2158-2162</Citation><ArticleIdList><ArticleId IdType="pubmed">29482433</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2013;8(3):e57755</Citation><ArticleIdList><ArticleId IdType="pubmed">23526951</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2017 Jan 26;376(4):330-341</Citation><ArticleIdList><ArticleId IdType="pubmed">25830322</ArticleId></ArticleIdList></Reference><Reference><Citation>Methods Mol Biol. 2013;969:29-42</Citation><ArticleIdList><ArticleId IdType="pubmed">23296925</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Med. 2005 Jul;11(7):786-90</Citation><ArticleIdList><ArticleId IdType="pubmed">15937495</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaccines (Basel). 2016 Nov 07;4(4):</Citation><ArticleIdList><ArticleId IdType="pubmed">27827980</ArticleId></ArticleIdList></Reference><Reference><Citation>Mol Ther. 2010 Jul;18(7):1357-64</Citation><ArticleIdList><ArticleId IdType="pubmed">20461061</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaccine. 2013 Feb 4;31(7):1026-33</Citation><ArticleIdList><ArticleId IdType="pubmed">23266342</ArticleId></ArticleIdList></Reference><Reference><Citation>Hum Vaccin. 2007 Sep-Oct;3(5):157-64</Citation><ArticleIdList><ArticleId IdType="pubmed">17637571</ArticleId></ArticleIdList></Reference><Reference><Citation>Mol Ther. 2012 May;20(5):948-53</Citation><ArticleIdList><ArticleId IdType="pubmed">22334017</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Struct Mol Biol. 2005 Dec;12(12):1054-63</Citation><ArticleIdList><ArticleId IdType="pubmed">16284618</ArticleId></ArticleIdList></Reference><Reference><Citation>J Virol. 2004 May;78(10):5458-65</Citation><ArticleIdList><ArticleId IdType="pubmed">15113924</ArticleId></ArticleIdList></Reference><Reference><Citation>J Immunol. 2005 Jul 15;175(2):633-9</Citation><ArticleIdList><ArticleId IdType="pubmed">16002657</ArticleId></ArticleIdList></Reference><Reference><Citation>J Immunol. 1997 Jul 1;159(1):11-4</Citation><ArticleIdList><ArticleId IdType="pubmed">9200432</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Biotechnol. 2012 Dec;30(12):1210-6</Citation><ArticleIdList><ArticleId IdType="pubmed">23159882</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Vaccine Immunol. 2015 Dec 16;23(3):189-95</Citation><ArticleIdList><ArticleId IdType="pubmed">26677198</ArticleId></ArticleIdList></Reference><Reference><Citation>J Virol. 2015 Oct 14;90(1):332-44</Citation><ArticleIdList><ArticleId IdType="pubmed">26468547</ArticleId></ArticleIdList></Reference><Reference><Citation>J Invest Dermatol. 2000 Apr;114(4):632-6</Citation><ArticleIdList><ArticleId IdType="pubmed">10733665</ArticleId></ArticleIdList></Reference><Reference><Citation>Cancer Immunol Immunother. 2006 Mar;55(3):246-53</Citation><ArticleIdList><ArticleId IdType="pubmed">16133114</ArticleId></ArticleIdList></Reference><Reference><Citation>Vet J. 1999 May;157(3):239-60</Citation><ArticleIdList><ArticleId IdType="pubmed">10328837</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc Natl Acad Sci U S A. 2014 Aug 26;111(34):12288-93</Citation><ArticleIdList><ArticleId IdType="pubmed">25136130</ArticleId></ArticleIdList></Reference><Reference><Citation>J Infect Dis. 2018 Jan 17;217(3):451-455</Citation><ArticleIdList><ArticleId IdType="pubmed">29281112</ArticleId></ArticleIdList></Reference><Reference><Citation>J Infect Dis. 2015 Feb 15;211(4):549-57</Citation><ArticleIdList><ArticleId IdType="pubmed">25225676</ArticleId></ArticleIdList></Reference><Reference><Citation>BMJ Open. 2015 Oct 28;5(10):e008748</Citation><ArticleIdList><ArticleId IdType="pubmed">26510727</ArticleId></ArticleIdList></Reference><Reference><Citation>J Control Release. 2016 Oct 28;240:227-234</Citation><ArticleIdList><ArticleId IdType="pubmed">26718856</ArticleId></ArticleIdList></Reference><Reference><Citation>J Infect Dis. 2015 Mar 15;211(6):947-55</Citation><ArticleIdList><ArticleId IdType="pubmed">25234719</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Med. 1998 Jan;4(1):37-42</Citation><ArticleIdList><ArticleId IdType="pubmed">9427604</ArticleId></ArticleIdList></Reference><Reference><Citation>Nucleic Acids Res. 2011 Nov;39(21):e142</Citation><ArticleIdList><ArticleId IdType="pubmed">21890902</ArticleId></ArticleIdList></Reference><Reference><Citation>Mol Ther. 2015 Sep;23(9):1456-64</Citation><ArticleIdList><ArticleId IdType="pubmed">26050989</ArticleId></ArticleIdList></Reference><Reference><Citation>Gene Ther. 1996 Mar;3(3):262-8</Citation><ArticleIdList><ArticleId IdType="pubmed">8646558</ArticleId></ArticleIdList></Reference><Reference><Citation>Biochem Biophys Res Commun. 2007 Jun 22;358(1):373-8</Citation><ArticleIdList><ArticleId IdType="pubmed">17475211</ArticleId></ArticleIdList></Reference><Reference><Citation>Hum Vaccin Immunother. 2013 Oct;9(10):2263-76</Citation><ArticleIdList><ArticleId IdType="pubmed">23921513</ArticleId></ArticleIdList></Reference><Reference><Citation>Mol Ther. 2003 Sep;8(3):495-500</Citation><ArticleIdList><ArticleId IdType="pubmed">12946323</ArticleId></ArticleIdList></Reference><Reference><Citation>Emerg Microbes Infect. 2013 Aug;2(8):e52</Citation><ArticleIdList><ArticleId IdType="pubmed">26038486</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaccine. 2017 Oct 27;35(45):6208-6217</Citation><ArticleIdList><ArticleId IdType="pubmed">28941620</ArticleId></ArticleIdList></Reference><Reference><Citation>J Virol. 2013 Feb;87(3):1359-72</Citation><ArticleIdList><ArticleId IdType="pubmed">23175355</ArticleId></ArticleIdList></Reference><Reference><Citation>Biologicals. 2014 Sep;42(5):223-36</Citation><ArticleIdList><ArticleId IdType="pubmed">25135887</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2013 Feb 7;368(6):551-60</Citation><ArticleIdList><ArticleId IdType="pubmed">23388006</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Vaccine Immunol. 2006 Nov;13(11):1267-77</Citation><ArticleIdList><ArticleId IdType="pubmed">16988008</ArticleId></ArticleIdList></Reference><Reference><Citation>Immunology. 2015 Oct;146(2):312-26</Citation><ArticleIdList><ArticleId IdType="pubmed">26173587</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Mater. 2013 Nov;12(11):967-77</Citation><ArticleIdList><ArticleId IdType="pubmed">24150415</ArticleId></ArticleIdList></Reference><Reference><Citation>Expert Opin Drug Deliv. 2016;13(2):295-310</Citation><ArticleIdList><ArticleId IdType="pubmed">26578324</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2009 Jun 18;360(25):2605-15</Citation><ArticleIdList><ArticleId IdType="pubmed">19423869</ArticleId></ArticleIdList></Reference><Reference><Citation>J Immunother. 2011 Jan;34(1):1-15</Citation><ArticleIdList><ArticleId IdType="pubmed">21150709</ArticleId></ArticleIdList></Reference><Reference><Citation>Trends Biotechnol. 2004 Jul;22(7):346-53</Citation><ArticleIdList><ArticleId IdType="pubmed">15245907</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS Biol. 2006 Jun;4(6):e180</Citation><ArticleIdList><ArticleId IdType="pubmed">16700628</ArticleId></ArticleIdList></Reference><Reference><Citation>J Control Release. 2015 Nov 10;217:337-44</Citation><ArticleIdList><ArticleId IdType="pubmed">26342664</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet Infect Dis. 2017 Dec;17(12):1276-1284</Citation><ArticleIdList><ArticleId IdType="pubmed">29033032</ArticleId></ArticleIdList></Reference><Reference><Citation>Nucleic Acids Res. 2016 Sep 19;44(16):7511-26</Citation><ArticleIdList><ArticleId IdType="pubmed">27317694</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaccine. 2016 Apr 29;34(20):2291-3</Citation><ArticleIdList><ArticleId IdType="pubmed">27015734</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc Natl Acad Sci U S A. 1995 May 9;92(10):4477-81</Citation><ArticleIdList><ArticleId IdType="pubmed">7753828</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Vaccine Immunol. 2017 Jan 5;24(1):</Citation><ArticleIdList><ArticleId IdType="pubmed">27535837</ArticleId></ArticleIdList></Reference><Reference><Citation>Br J Pharmacol. 2009 May;157(2):153-65</Citation><ArticleIdList><ArticleId IdType="pubmed">18776913</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Rev Drug Discov. 2018 Apr;17(4):261-279</Citation><ArticleIdList><ArticleId IdType="pubmed">29326426</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc Natl Acad Sci U S A. 2012 Sep 4;109(36):14604-9</Citation><ArticleIdList><ArticleId IdType="pubmed">22908294</ArticleId></ArticleIdList></Reference><Reference><Citation>Expert Rev Vaccines. 2015 Feb;14(2):221-34</Citation><ArticleIdList><ArticleId IdType="pubmed">25540984</ArticleId></ArticleIdList></Reference><Reference><Citation>NPJ Vaccines. 2016 Nov 10;1:16021</Citation><ArticleIdList><ArticleId IdType="pubmed">29263859</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 2003 May 15;423(6937):240</Citation><ArticleIdList><ArticleId IdType="pubmed">12748632</ArticleId></ArticleIdList></Reference><Reference><Citation>J Infect Dis. 2012 Mar 1;205(5):772-81</Citation><ArticleIdList><ArticleId IdType="pubmed">22275401</ArticleId></ArticleIdList></Reference><Reference><Citation>Virology. 2007 Mar 30;360(1):36-49</Citation><ArticleIdList><ArticleId IdType="pubmed">17098273</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaccine. 2015 Sep 22;33(39):5225-34</Citation><ArticleIdList><ArticleId IdType="pubmed">26143613</ArticleId></ArticleIdList></Reference><Reference><Citation>Mol Biotechnol. 2004 Jun;27(2):109-18</Citation><ArticleIdList><ArticleId IdType="pubmed">15208453</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet Infect Dis. 2015 Sep;15(9):1041-1048</Citation><ArticleIdList><ArticleId IdType="pubmed">26333337</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet Infect Dis. 2016 Mar;16(3):311-20</Citation><ArticleIdList><ArticleId IdType="pubmed">26725450</ArticleId></ArticleIdList></Reference><Reference><Citation>Methods Mol Biol. 2013;969:43-54</Citation><ArticleIdList><ArticleId IdType="pubmed">23296926</ArticleId></ArticleIdList></Reference><Reference><Citation>Swiss Med Wkly. 2017 Aug 14;147:w14465</Citation><ArticleIdList><ArticleId IdType="pubmed">28804866</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaccine. 2016 Dec 12;34(51):6610-6616</Citation><ArticleIdList><ArticleId IdType="pubmed">27346303</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaccine. 2016 Dec 7;34(50):6436-6448</Citation><ArticleIdList><ArticleId IdType="pubmed">28029542</ArticleId></ArticleIdList></Reference><Reference><Citation>J Transl Med. 2017 Jan 3;15(1):1</Citation><ArticleIdList><ArticleId IdType="pubmed">28049494</ArticleId></ArticleIdList></Reference><Reference><Citation>J Immunol. 2017 May 15;198(10):4012-4024</Citation><ArticleIdList><ArticleId IdType="pubmed">28416600</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2016 Aug 15;11(8):e0161193</Citation><ArticleIdList><ArticleId IdType="pubmed">27525409</ArticleId></ArticleIdList></Reference><Reference><Citation>Curr Opin HIV AIDS. 2010 Sep;5(5):404-8</Citation><ArticleIdList><ArticleId IdType="pubmed">20978381</ArticleId></ArticleIdList></Reference><Reference><Citation>Genes Dis. 2017 Jun;4(2):43-63</Citation><ArticleIdList><ArticleId IdType="pubmed">28944281</ArticleId></ArticleIdList></Reference><Reference><Citation>Hum Vaccin Immunother. 2016 May 3;12(5):1102-16</Citation><ArticleIdList><ArticleId IdType="pubmed">26631840</ArticleId></ArticleIdList></Reference><Reference><Citation>Hum Vaccin Immunother. 2017 Jan 2;13(1):153-168</Citation><ArticleIdList><ArticleId IdType="pubmed">27764560</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet. 2017 Sep 23;390(10101):1511-1520</Citation><ArticleIdList><ArticleId IdType="pubmed">28754494</ArticleId></ArticleIdList></Reference><Reference><Citation>RNA. 2001 Oct;7(10):1486-95</Citation><ArticleIdList><ArticleId IdType="pubmed">11680853</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaccines (Basel). 2015 May 26;3(2):429-47</Citation><ArticleIdList><ArticleId IdType="pubmed">26343196</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaccine. 2017 Aug 16;35(35 Pt A):4470-4474</Citation><ArticleIdList><ArticleId IdType="pubmed">28633891</ArticleId></ArticleIdList></Reference><Reference><Citation>Viruses. 2014 Apr 17;6(4):1759-88</Citation><ArticleIdList><ArticleId IdType="pubmed">24747773</ArticleId></ArticleIdList></Reference><Reference><Citation>RNA Biol. 2012 Nov;9(11):1319-30</Citation><ArticleIdList><ArticleId IdType="pubmed">23064118</ArticleId></ArticleIdList></Reference><Reference><Citation>Expert Rev Vaccines. 2017 Sep;16(9):871-881</Citation><ArticleIdList><ArticleId IdType="pubmed">28701102</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2003 Dec 18;349(25):2431-41</Citation><ArticleIdList><ArticleId IdType="pubmed">14681510</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 2017 Mar 9;543(7644):248-251</Citation><ArticleIdList><ArticleId IdType="pubmed">28151488</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet. 2018 Feb 10;391(10120):552-562</Citation><ArticleIdList><ArticleId IdType="pubmed">29217376</ArticleId></ArticleIdList></Reference><Reference><Citation>Mol Ther. 2018 Feb 7;26(2):446-455</Citation><ArticleIdList><ArticleId IdType="pubmed">29275847</ArticleId></ArticleIdList></Reference><Reference><Citation>Genes Dev. 1991 Nov;5(11):2108-16</Citation><ArticleIdList><ArticleId IdType="pubmed">1682219</ArticleId></ArticleIdList></Reference><Reference><Citation>Gene Ther. 2017 Mar;24(3):133-143</Citation><ArticleIdList><ArticleId IdType="pubmed">28094775</ArticleId></ArticleIdList></Reference><Reference><Citation>Mol Ther. 2017 Dec 6;25(12):2635-2647</Citation><ArticleIdList><ArticleId IdType="pubmed">28958578</ArticleId></ArticleIdList></Reference><Reference><Citation>J Exp Med. 1998 Sep 21;188(6):1075-82</Citation><ArticleIdList><ArticleId IdType="pubmed">9743526</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2016 Apr 28;374(17):1647-60</Citation><ArticleIdList><ArticleId IdType="pubmed">25830326</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></pubmed><affiliations><list><country><li>Allemagne</li></country><region><li>Bade-Wurtemberg</li><li>District de Tübingen</li></region><settlement><li>Tübingen</li></settlement></list><tree><country name="Allemagne"><region name="Bade-Wurtemberg"><name sortKey="Rauch, Susanne" sort="Rauch, Susanne" uniqKey="Rauch S" first="Susanne" last="Rauch">Susanne Rauch</name></region><name sortKey="Jasny, Edith" sort="Jasny, Edith" uniqKey="Jasny E" first="Edith" last="Jasny">Edith Jasny</name><name sortKey="Petsch, Benjamin" sort="Petsch, Benjamin" uniqKey="Petsch B" first="Benjamin" last="Petsch">Benjamin Petsch</name><name sortKey="Schmidt, Kim E" sort="Schmidt, Kim E" uniqKey="Schmidt K" first="Kim E" last="Schmidt">Kim E. Schmidt</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SrasV1/Data/PubMed/Checkpoint
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000985 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd -nk 000985 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= SrasV1
|flux= PubMed
|étape= Checkpoint
|type= RBID
|clé= pubmed:30283434
|texte= New Vaccine Technologies to Combat Outbreak Situations.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/RBID.i -Sk "pubmed:30283434" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd \
| NlmPubMed2Wicri -a SrasV1
| This area was generated with Dilib version V0.6.33. |  |